What changed
Jalen Hurts played Philadelphia’s full game against Jacksonville in London on 11 October, hours after doctors found a superficial blood clot in his calf.
A later scan showed the clot had moved. Further tests found deep-vein thrombosis and multiple clots in both lungs. Hurts will take blood-thinning medicine, is expected to make a full recovery and will probably miss the rest of the season.
Why it matters
This was not a routine injury decision. Hurts was evaluated at Cleveland Clinic, cleared to play and then cleared to fly home. The NFL’s chief medical officer said the league has no protocol covering a case like this, while the NFL Players Association called for a full investigation.
The timeline is now the central issue:
- Hurts reported a problem on 8 October.
- He trained fully during the week.
- An ultrasound on 10 October found the calf clot.
- He played the entire game the next day.
- A follow-up scan within the recommended 72 hours showed the clot had moved.
- He was later diagnosed with clots in both lungs.
The informed view is that the case will test the gap between a player being medically cleared in the moment and the risks that may emerge afterward. If the joint NFL-NFLPA review finds that existing guidance was inadequate, the league may have to decide how similar cases should be assessed before international games, travel and competition.
For Hurts, the immediate priority is treatment and recovery. For the Eagles, it means losing their starting quarterback for the remainder of a season they had expected him to lead. For the NFL, the question is whether a medical decision that was considered acceptable at the time still looks acceptable once the full chain of events is known.
Comments
No comments yet.